Healthy adults
Conditions
Interventions
Dissolve Jerusalem artichoke inulin-containing product (test product) in a beverage or others. Drink it once daily.
Dissolve placebo in a beverage or others. Drink it once daily.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. BMI of 23.0 kg/m2 to < 30.0 kg/m2 2. Those who are slightly constipated and have 3 to 5 stools per week. 3. Those whose constipation symptoms have lasted for more than 3 months. 4. Those who do not change or do not intend to change daily life habits during the study period. 5. Those who can provide their written informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who are currently receiving some types of drug treatment, for example, treatment affecting obesity, hyperlipidemia, lipid metabolism, and harmonious intestinal action (except for the drugs that are taken as needed in those with complications or living with chronic diseases). 2. Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 3. Those who cannot stop taking health foods or supplements during the study period. 4. Those who cannot stop drinking alcohol the day before a test. 5. Those who have a current or a past medical history of severe diseases. 6. Those who have a current or a past medical history of drug or food allergy. 7. Those who have a current or a past medical history of drug or alcohol dependence. 8. Those who have metals implanted in the body due to surgery etc. 9. Those who have a cardiac pacemaker or an implantable medical device placed in the body. 10. Those who have claustrophobia. 11. Smokers. 12. Those who work night shifts. 13. Those who are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 14. Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 15. Those who were determined by the principal investigator to be an unsuitable subject for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visceral fat area (V), Subcutaneous fat area (S), Total fat area, Weight, Body mass index (BMI), and Waist circumference. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stool test (a simple analysis to see changes in bacterial population using T-RFLP), Defecation questionnaire, TG, T-Cho, HDL-C, LDL-C, HbA1c, Blood glucose levels, and Serum uric acid levels. | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed